Eur J Nucl Med Mol Imaging (2017) 44:1611–1613 DOI 10.1007/s00259-017-3767-4 EDITORIAL COMMENTARY A new perspective for nuclear medicine: expanding the indications for PSMA targeted imaging and therapy 1 1 Frederik A. Verburg & Markus Luster Received: 20 June 2017 /Accepted: 21 June 2017 /Published online: 4 July 2017 Springer-Verlag GmbH Germany 2017 The erroneously named prostate specific membrane antigen Furthermore, even well before the introduction of PSMA (PSMA), also known by the functional description of targeted imaging and therapy it was already shown in immu- glutamatedecarboxypeptidase 2,has inrecentyears seena mas- nohistochemical studies that PSMA is also expressed in a sive upsurge in interest in nuclear medicine due to the newly variety of solid malignancies including e.g. breast cancer and gliomas . Incidental findings on PSMA PET/CT per- available specific functional substrate tracers for both positron emission tomography (PET) imaging and radionuclide therapy formed for prostate cancer have already expanded this list of [1–12]. Because of its superior characteristics [13–15]PSMA PSMA expressing tumours by e.g. renal cell carcinoma and targetedimagingandtherapyhasbecomepartofroutineclinical thyroid cancer [23–31]. care in an almost unprecedented rapid adoption process and has However, in most non-prostate neoplasms PSMA is not replaced the previous clinical standard wherever the necessary expressed
European Journal of Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Jul 4, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera